BCAL Diagnostics Balance Sheet Health
Financial Health criteria checks 5/6
BCAL Diagnostics has a total shareholder equity of A$8.6M and total debt of A$641.3K, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are A$12.3M and A$3.7M respectively.
Key information
7.5%
Debt to equity ratio
AU$641.34k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$6.47m |
| Equity | AU$8.59m |
| Total liabilities | AU$3.68m |
| Total assets | AU$12.27m |
Financial Position Analysis
Short Term Liabilities: BDX's short term assets (A$9.3M) exceed its short term liabilities (A$2.6M).
Long Term Liabilities: BDX's short term assets (A$9.3M) exceed its long term liabilities (A$1.1M).
Debt to Equity History and Analysis
Debt Level: BDX has more cash than its total debt.
Reducing Debt: BDX's debt to equity ratio has increased from 0% to 7.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BDX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: BDX is forecast to have sufficient cash runway for 12 months based on free cash flow estimates, but has since raised additional capital.